Endocrine oncology

Postoperative Unstimulated Thyroglobulin Accurately Predicts Outcomes in High‐Risk Differentiated Thyroid Cancer: A Retrospective Cohort Study

Clin Endocrinol (Oxf)Published Retrospective cohort study

Authors' conclusion

Postoperative UTg is a strong prognostic marker in high-risk DTC patients, providing a non-inferior alternative to STg with greater accessibility and fewer side effects. We propose a clinical algorithm to optimize the management of these cases. When UTg levels exceed 2.1 ng/mL, particularly higher than 3.8 ng/mL, investigation of potentially resectable metastatic foci should be considered before radioiodine therapy. Prospective studies are needed to validate this algorithm.

Study context

Population
High-risk differentiated thyroid cancer (DTC) patients at two Brazilian tertiary hospitals (144 high-risk of 1000 DTC patients identified)met inclusion criteria
Participants
57 patients
Exposure
Postoperative unstimulated thyroglobulin (UTg) vs stimulated thyroglobulin (STg) for predicting outcomes and metastases
Outcome
Prognostic value of postoperative UTg for outcomes:
  • Favorable: excellent/indeterminate responses
  • Unfavorable: biochemical/structural incomplete responses
Follow-up
1 year
Methodological detailstwo Brazilian tertiary hospitals, 2015-2024
  • Two Brazilian tertiary hospitals
  • 2015-2024

Main finding

As reported in the abstract

Prediction of outcomes by UTg · 1-year
GroupValueSensitivitySpecificityAccuracy
UTgcutoff 2.1 ng/mL83.3%96.0%90.7%

UTg

Valuecutoff 2.1 ng/mL
Sensitivity83.3%
Specificity96.0%
Accuracy90.7%
  • UTg vs STg: P = 0.964 — non-inferiority of UTg to STg in predicting outcomes
UTg independent risk factor for 1-year outcomes (OR)
0.008; 95% CI: 0.001-0.088; p < 0.001

Observational data: associations, not effects.

Further findings

OutcomeP value
Non-inferiority of UTg to STg in predicting outcomes and metastasisUTg vs STg · predicting outcomes; non-inferiorityP = 0.964
Non-inferiority of UTg to STg in predicting outcomes and metastasisUTg vs STg · predicting metastasis; non-inferiorityP = 0.980

Metastases: UTg cutoff of 3.8 ng/mL

UTg cutoff identifying metastases
3.8 ng/mL
Sensitivity
86.4%
Specificity
90.5%

Predictors of unfavorable outcomes

Advanced age
P = 0.048
Larger tumor size
P = 0.002
Higher UTg
P < 0.001
Higher STg
P < 0.001

Original publication

Postoperative Unstimulated Thyroglobulin Accurately Predicts Outcomes in High‐Risk Differentiated Thyroid Cancer: A Retrospective Cohort Study. Clin Endocrinol (Oxf). Published 4 May 2025. doi:10.1111/cen.15260

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.